74 related articles for article (PubMed ID: 26172928)
1. Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study.
Lello S; Sorge R; Surico N;
Gynecol Endocrinol; 2015; 31(12):992-8. PubMed ID: 26172928
[TBL] [Abstract][Full Text] [Related]
2. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
3. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
Baró F; Cano A; Sánchez Borrego R; Ferrer J; González Rodríguez SP; Neyro JL; Rodriguez Bueno E; Sancho C; Inaraja V; Fernández C; Corral C;
Menopause; 2012 Nov; 19(11):1193-9. PubMed ID: 22948137
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).
Sund R; Honkanen R; Johansson H; Odén A; McCloskey E; Kanis J; Kröger H
Calcif Tissue Int; 2014 Jul; 95(1):39-45. PubMed ID: 24792689
[TBL] [Abstract][Full Text] [Related]
5. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
Watts NB
J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
[TBL] [Abstract][Full Text] [Related]
6. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
González-Macías J; Marin F; Vila J; Díez-Pérez A
Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
[TBL] [Abstract][Full Text] [Related]
7. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
[TBL] [Abstract][Full Text] [Related]
8. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
[TBL] [Abstract][Full Text] [Related]
9. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
[TBL] [Abstract][Full Text] [Related]
10. [Ten-year fracture risk by FRAX(®) of women with osteoporosis attending osteoporosis care in Hungary].
Péntek M; Gulácsi L; Tóth E; Baji P; Brodszky V; Horváth C
Orv Hetil; 2016 Jan; 157(4):146-53. PubMed ID: 26772827
[TBL] [Abstract][Full Text] [Related]
11. Classification of functioning and assessment of fracture risk of a large Italian osteoporotic population. The Physiatric Approach To Osteoporosis project.
Gimigliano F; Moretti A; Riccio I; Letizia Mauro G; Gimigliano R; Iolascon G
Eur J Phys Rehabil Med; 2015 Oct; 51(5):529-38. PubMed ID: 25994371
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis among older Saudis: risk of fractures and unmet needs.
Amin TT; Al Owaifeer A; Al-Hashim H; Alwosaifer A; Alabdulqader M; Al Hulaibi F; Al Hamam A
Arch Osteoporos; 2013; 8():118. PubMed ID: 23361436
[TBL] [Abstract][Full Text] [Related]
13. The burden of osteoporotic fractures: a method for setting intervention thresholds.
Kanis JA; Oden A; Johnell O; Jonsson B; de Laet C; Dawson A
Osteoporos Int; 2001; 12(5):417-27. PubMed ID: 11444092
[TBL] [Abstract][Full Text] [Related]
14. [Comparison fracture risk calculated by FRAX tool].
Carranza-Lira S; Lanuza-López MC; Sandoval-Barragán MP
Ginecol Obstet Mex; 2014 Sep; 82(9):591-4. PubMed ID: 25412552
[TBL] [Abstract][Full Text] [Related]
15. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.
Pluskiewicz W; Adamczyk P; Franek E; Leszczynski P; Sewerynek E; Wichrowska H; Napiorkowska L; Kostyk T; Stuss M; Stepien-Klos W; Golba KS; Drozdzowska B
Bone; 2010 Jun; 46(6):1661-7. PubMed ID: 20156606
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
Yu R; Leung J; Woo J
J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
[TBL] [Abstract][Full Text] [Related]
17. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.
Ray NF; Chan JK; Thamer M; Melton LJ
J Bone Miner Res; 1997 Jan; 12(1):24-35. PubMed ID: 9240722
[TBL] [Abstract][Full Text] [Related]
18. Burden of postmenopausal osteoporosis in Germany: estimations from a disease model.
Gauthier A; Kanis JA; Jiang Y; Dreinhöfer K; Martin M; Compston J; Borgström F; Cooper C; McCloskey E
Arch Osteoporos; 2012; 7():209-18. PubMed ID: 23196864
[TBL] [Abstract][Full Text] [Related]
19. Risk factors predicting fractures in early postmenopausal women.
Pfister AK; Welch CA; Emmett MK; Sheets NW
W V Med J; 2013; 109(3):8-12, 14-5. PubMed ID: 23798274
[TBL] [Abstract][Full Text] [Related]
20. Identification of osteopenic women at high risk of fracture: the OFELY study.
Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]